CTX — Crescita Therapeutics Share News
0.000.00%
- CA$14.71m
- CA$8.50m
- CA$21.12m
Brief: Strategic partner Intega Skin Sciences Inc,acquired by Crescita Therapeutics Inc
Brief: Crescita Therapeutics acquires Intega Skin Sciences
Brief: Crescita Therapeutics qtrly total revenue was $0.2 mln vs $0.3 mln last year
Brief: Crescita Therapeutics provides update on immunology group wind-down
Brief: Crescita Therapeutics announces Q1 results
Brief: Crescita Therapeutics says evaluating strategic merger and acquisition opportunities